SCHEMBL9905271

SCHEMBL9905271

CC(C)(C)NC(=NC(=O)c1ccc(C(F)(F)F)cc1)Nc1cc(-c2cccc(O)c2)n[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 2/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
RAF1 P04049 4/20 0.39
BRAF P15056 2/20 0.39
BAZ1A Q9NRL2 1/20 0.36
MLLT3 P42568 1/20 0.36
MLLT1 Q03111 1/20 0.36
ACR P10323 2/20 0.35
TRPV1 Q8NER1 1/20 0.35
KDM4E B2RXH2 1/20 0.35
THRB P10828 1/20 0.35
NLRP3 Q96P20 1/20 0.34
HDAC6 Q9UBN7 2/20 0.34
TLR7 Q9NYK1 1/20 0.34
P2RX1 P51575 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9905267 1.00 SNCA (0.41) SNCAMAPTMEN1NPC1LMNA
SCHEMBL18558394 0.91 RAF1 (0.39) SNCARAF1BRAFACRHDAC6
SCHEMBL19360275 0.91 MAPT (0.39) MAPTNPC1LMNARAF1BRAF
SCHEMBL18558030 0.91 GRM5 (0.41) SNCAMAPTNPC1RAF1BRAF
SCHEMBL9905362 0.90 SNCA (0.48) SNCAMAPTLMNAACRTRPV1
SCHEMBL17088955 0.90 MAPT (0.38) SNCAMAPTNPC1RAB9ARAF1
SCHEMBL9905358 0.90 SNCA (0.48) SNCAMAPTLMNAACRTRPV1
SCHEMBL17089717 0.87 SNCA (0.41) SNCAMAPTMEN1NPC1LMNA
SCHEMBL18558123 0.86 SNCA (0.41) SNCAMAPTRAB9ARAF1BRAF
SCHEMBL18558333 0.86 SNCA (0.41) SNCAMAPTACRKDM4ETHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648511-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Lycera Corporation (US) 2013-10-16 EP disclosed
WO-2012078874-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed